ICIn Young Choi

In Young Choi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


In Young Choi has a total of 16 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Risk Stratification of Long-Term Mortality in Infants with Congenital Diaphragmatic Hernia Using the National Health Insurance Service (NHIS) Data

    by Hye Ji Han, Min Ji Suh, In Young Choi, Ji Soo Park, Hwan Soo Kim, Hyeon-Jong Yang, Dong In Suh, Eun Lee, Kyung Hoon Kim

    Background: Congenital diaphragmatic hernia (CDH) is a rare but serious congenital anomaly linked to high mortality rates and significant long-term morbidity. Although numerous prognostic factors for short-term outcomes have been identified through hospital-based studies, data on long-term mortality at the population level are limited. Specifically, nationwide assessments of long-term outcomes for infants with CDH are scarce. This study aimed to estimate the national 5-year all-cause mortality for CDH and to create a population-level risk stratification nomogram utilizing nationwide health insurance claims data. Methods: We conducted a retrospective cohort study of infants with CDH using nationwide insurance claims data from 2002 to 2016, allowing for complete 5-year follow-up. We analyzed population-level demographic and clinical proxy variables with Cox proportional hazards models and developed a nomogram for long-term mortality risk stratification. Results: Factors such as rural residence, middle-to-high SES, respiratory distress in newborns, and CHD were associated with increased 5-year mortality in infants with CDH. The claims-based nomogram, which incorporated sociodemographic and comorbidity variables, demonstrated moderate discriminatory power (AUC 0.76; C-index 0.78) for population-level risk stratification. Conclusions: This nationwide claims-based cohort study provides population-level estimates of 5-year mortality associated with CDH and introduces a nomogram that offers moderate discriminatory ability for long-term risk stratification.


  • Association between corticosteroid use and fracture risk in children with asthma: A nationwide cohort study

    by Hyunmin Ji, Hye‐Ji Han, In‐Young Choi, Eun Lee, Hwan Soo Kim, Hyeon‐Jong Yang, Gahgene Gweon, Kyunghoon Kim

    Background: Pediatric asthma, as a chronic inflammatory condition, has been associated with increased fracture risk due to persistent inflammation and corticosteroid treatment. This study investigates the association between pediatric asthma and fracture risk using data from the National Health Insurance Service database of South Korea. Methods: Children born from 2002 to 2004 were selected for the analysis, utilizing information from the Korean National Health Insurance Service National Sample Cohort up to 2019. Exclusion criteria included asthma diagnosis before age 6, history of prior fractures, and the presence of severe comorbidities. Asthma cases were identified by the Korean Standard Classification of Diseases, 8th Revision (KCD‐8) codes J45 and J46, and fractures were determined using all relevant KCD‐8 codes. Propensity score matching was used to balance demographic and clinical characteristics between the asthma and non‐asthma groups. Fracture risk was analyzed using logistic regression models adjusted for covariates. Within the asthma cohort, the analysis investigated corticosteroid exposure, focusing on both recent and cumulative exposure to inhaled corticosteroids (ICS) and systemic corticosteroids within 1 year before the occurrence of fractures. Results: From an initial cohort of 30,409 children, 13,275 were included in the final analysis, comprising 2325 asthma patients and 10,950 non‐asthma controls. Asthma was associated with a higher risk of fractures (Odds Ratio [OR]: 1.22, 95% CI: 1.12–1.34, p < .001). Among asthma patients, recent ICS use within 90 days before a fracture was linked to the highest risk (Adjusted Odds Ratio [Adjusted OR]: 2.98, 95% CI: 2.95–3.05, p < .001). Systemic corticosteroid use showed a dose‐dependent relationship with increased fracture risk. Conclusion: Pediatric asthma and corticosteroid treatment are both significantly associated with elevated fracture risk. These results emphasize the necessity for comprehensive asthma management strategies that prioritize bone health.


  • Open Access

    Dexmedetomidine in Mechanically Ventilated Critically Ill Children: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

    by In Kyung Lee, Kyeong Hun Lee, Hye-Ji Han, In Young Choi, Na Jin Kim, Kyunghoon Kim

    Lee IK, et al. Yonsei Med J. 2025 May;66:e50. https://doi.org/10.3349/ymj.2024.0299